A detailed history of Abel Hall, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Abel Hall, LLC holds 5,261 shares of MRK stock, worth $535,990. This represents 0.46% of its overall portfolio holdings.

Number of Shares
5,261
Previous 5,099 3.18%
Holding current value
$535,990
Previous $673 Million 3.2%
% of portfolio
0.46%
Previous 0.5%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

BUY
$123.8 - $132.96 $20,055 - $21,539
162 Added 3.18%
5,261 $651 Million
Q1 2024

May 08, 2024

BUY
$113.24 - $131.95 $9,851 - $11,479
87 Added 1.74%
5,099 $673 Million
Q4 2023

Feb 28, 2024

BUY
$100.18 - $109.02 $502,102 - $546,408
5,012 New
5,012 $546 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $258B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Abel Hall, LLC Portfolio

Follow Abel Hall, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abel Hall, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Abel Hall, LLC with notifications on news.